- Oops!Something went wrong.Please try again later.
CEO Tim Moore to present and host a Q & A for investors on December 8 at 2:30pm EST
VANCOUVER, BC, Dec. 3, 2021 /CNW/ - Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "Havn Life") a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support brain health and enhance the capabilities of the mind, is announcing that CEO Tim Moore will be presenting at the SNN Network Canada Virtual Event 2021 on Wednesday, December 8 at 2:30pm EST. Mr. Moore will also host a Q & A session for investors following his presentation.
The event is a platform for investors to learn about the highest quality public MicroCap companies listed on Canadian exchanges, as well as hear from fund managers, newsletter writers and financial influencers with experience and expertise investing in these Canadian assets.
HAVN Life presentation at SNN Network Canada Virtual Event
Wednesday, Dec. 8th at 2:30 PM Eastern (11:30 AM Pacific)
Click this link to access the HAVN Life live presentation
One-on-one meetings will be scheduled and conducted via private, secure video conference through the conference event platform.
To book a one-on-one investor meeting with HAVN Life and to watch the company's presentation, please make sure you are registered for the virtual event here: https://canada.snn.network/signup
If you are unable to attend the live presentation, all company presentations will be available directly on the conference event platform on this link under the tab "Agenda": https://canada.snn.network/agenda
On Behalf of The Board of Directors
Chief Executive Officer
About HAVN Life Sciences Inc.
HAVN Life Sciences is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products, and innovative therapies to support brain health and enhance the capabilities of the mind.
Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, HAVN Life offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.
SNN.Network is your multimedia financial news platform for discovery, transparency and due diligence. This is your one-stop hub to find new investment ideas, check in on watchlist, gather the most up-to-date information on the Small-, Micro-, Nano-Cap market with the goal to help you towards achieving your wealth generation goals. Follow the companies YOU want to know more about; read and watch content from YOUR favorite finance and investing influencers; create YOUR own watchlist and screen for ideas YOU'RE interested in; find out about investor conferences YOU want to attend - all here on SNN Network.
If you would like to attend the SNN Network Summer Virtual Event 2021, please register here: https://conference.snn.network/signup
Forward-Looking Information: This news release contains "forward-looking information" within the meaning of applicable securities laws relating to statements regarding Mr. Moore's attendance and presentation at the SNN Network Canada Virtual Event 2021, the Company's business, products and future of the Company's business. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risk that Mr. Moore will not be able to attend and/or present at the SNN Network Canada Virtual Event 2021 as contemplated, or at all, risks that the Company's products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release.
SOURCE HAVN Life Sciences Inc.
View original content: http://www.newswire.ca/en/releases/archive/December2021/03/c3575.html